New York, New York 10065


The purpose of this study is to identify specific clinical and molecular characteristics that are predictive of tumor progression in small thyroid cancers.


Inclusion Criteria: - Biopsy proven papillary thyroid cancer (or suspicious for papillary thyroid cancer) confirmed by MSKCC cytopathologist. - Being followed with active surveillance at MSKCC - Biopsied index nodule less than or equal to 2 cm in maximum dimension - Thyroid and neck US performed and interpreted by a MSKCC radiologist within 6 months prior to study entry. Exclusion Criteria: - Biopsied index nodule greater than 2 cm in any dimension - Age less than 18 yrs old



Primary Contact:

Principal Investigator
Robert Tuttle, MD
Memorial Sloan Kettering Cancer Center

Robert Tuttle, MD
Phone: 646-888-2716

Backup Contact:

Michael Berger, PhD
Phone: 646-888-3386

Location Contact:

New York, New York 10065
United States

Robert Tuttle, MD
Phone: 646-888-2716

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.